Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SRT3.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 37.57 2.02 1.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -46.07 17.11 31.72
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 29.23 39.05 30.22
Cash 190.89 16.76 5.76
Capex -2.07 -1.88 -1.84
Free Cash Flow -50.30 -1.35 2.71
Revenue -3.55 11.98 12.42
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 24.07 0.48 0.39
Operating Margin 123.20 0.18 0.08
ROA -51.11 < 0.005 < 0.005
ROE -58.78 0.01 0.03
ROIC 199.17 0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SRT3.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SRT3.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SRT3.DE is permitted for members.